BNP Paribas Financial Markets’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.29M Buy
322,263
+159,687
+98% +$3.7M ﹤0.01% 1758
2026
Q1
$3.34M Buy
162,576
+32,472
+25% +$732K ﹤0.01% 2329
2025
Q4
$3.08M Buy
130,104
+41,224
+46% +$1M ﹤0.01% 2347
2025
Q3
$2.21M Sell
88,880
-66,617
-43% -$1.43M ﹤0.01% 2541
2025
Q2
$3.58M Sell
155,497
-39,043
-20% -$904K ﹤0.01% 2079
2025
Q1
$4.37M Sell
194,540
-26,506
-12% -$616K ﹤0.01% 1900
2024
Q4
$4.32M Buy
+221,046
New +$4.38M ﹤0.01% 1879

Other funds holding PRVA

BNP Paribas Financial Markets's PRVA Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Privia Health (PRVA) stake by 98% in Q2 2026, buying an estimated $3.7M and bringing the position to 322,263 shares worth $8.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1758.

BNP Paribas Financial Markets first reported a position in PRVA in Q4 2024 and has held it in 7 quarters since. 281 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • BNP Paribas Financial Markets held 322,263 shares of Privia Health worth $8.29M as of Q2 2026.
  • BNP Paribas Financial Markets bought 159,687 Privia Health shares in Q2 2026, an estimated $3.7M.
  • Privia Health made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #1758 holding.
  • BNP Paribas Financial Markets first reported a position in Privia Health in Q4 2024 and has held it in 7 quarters since.
  • 281 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.